4,5-dichloro-N-(quinolin-8-yl)thiophene-2-sulfonamide | 877219-34-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 4,5-dichloro-N-(quinolin-8-yl)thiophene-2-sulfonamide
• 英文别名: 4,5-dichloro-thiophene-2-sulfonic acid quinolin-8-ylamide；4,5-dichloro-N-quinolin-8-ylthiophene-2-sulfonamide
• CAS: 877219-34-6
• 化学式: C₁₃H₈Cl₂N₂O₂S₂
• 分子量: 359.257
• InChiKey: ZPVBTGCRVZKUBL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  95.7
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  8-氨基喹啉 、 2,3-二氯-5-氯磺酰基噻吩 在 吡啶 作用下， 反应 0.05h， 以81%的产率得到4,5-dichloro-N-(quinolin-8-yl)thiophene-2-sulfonamide
  参考文献：
  名称：

  从传感器到消音器：作为锌蛋白酶抑制剂的喹啉和苯并咪唑磺酰胺

  摘要：

  源自小分子锌 (II) 离子传感器领域的广泛工作，已经制备了喹啉和苯并咪唑磺酰胺的螯合片段库，并针对几种不同的锌 (II) 依赖性基质金属蛋白酶 (MMP) 进行了筛选。基于螯合基团的性质，这些片段显示出对这些金属酶的显着抑制和对不同 MMP 的偏好。研究结果表明，聚焦螯合剂文库是发现用于金属蛋白抑制的先导片段的有力策略。

  DOI：

  10.1021/ja101088j

文献信息

• PDE4B INHIBITORS AND USES THEREFOR
  申请人：Ibrahim Prabha N.

  公开号：US20090286793A1

  公开（公告）日：2009-11-19

  Compounds active on phosphodiesterase PDE4B are provided. Also provided herewith are compositions useful for treatment of PDE4B-mediated diseases or conditions, and methods for the use thereof.

  本发明提供了对磷酸二酯酶PDE4B活性作用的化合物。同时还提供了用于治疗PDE4B介导的疾病或病状的组合物以及其使用方法。
• COMPOSITION AND METHODS FOR THE DESIGN AND DEVELOPMENT OF METALLO-ENZYME INHIBITORS
  申请人：Pellecchia Maurizio

  公开号：US20100041653A1

  公开（公告）日：2010-02-18

  The present disclosure provides compounds having the general structure A or pharmaceutically acceptable salts thereof: R—X  (A) wherein R is an alkyl or aryl moiety comprising heterocyclic structures; and X is a metal-chelatin group selected from: This disclosure further provides a focused library of compounds for use in the discovery and design of metallo-enzyme inhibitors. This fragment-based approach provides an assembly of a library of low molecular weight compounds (MW<300 Da) containing a variety of potential metal-chelating groups. The identification of the inhibitory scaffolds among these compounds provides the initial hit fragments that may be optimized for affinity against a particular target using common medicinal chemistry, structure-based or NMR-based approaches.
• N-QUINOLIN-BENZENSULFONAMIDES AND RELATED COMPOUNDS FOR THE TREATMENT OF CANCER, AUTOIMMUNE DISORDERS AND INFLAMMATION
  申请人：The Trustees of Columbia University in the City of New York

  公开号：US20140073668A1

  公开（公告）日：2014-03-13

  The present invention relates to the NQBS class of molecules. It is based, at least in part, on the discovery that a representative group of compounds have been observed to inhibit nuclear translocation of NF-κB subunits. Without being bound by any particular theory, this inhibition of nuclear translocation may be mediated by either (i) binding of the NQBS or related compound to the C-terminus of the RHD, which specifically mediates the nuclear internalization; or (ii) NQBS-mediated stabilization of the dimer/IκB complex, disallowing dissociation of the active NF-κB monomers, and thus, inhibiting the generation of the subunits necessary to enter the nucleus. The NQBS class of molecules, and related molecules, may be used in therapeutic applications where inhibition of NF-κB translocation is beneficial, including but not limited to the treatment of cancer, autoimmune disorders, and inflammatory states.
• US7585859B2
  申请人：——

  公开号：US7585859B2

  公开（公告）日：2009-09-08
• US8470821B2
  申请人：——

  公开号：US8470821B2

  公开（公告）日：2013-06-25